Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 929
Healthy volunteers: no

Brief summary:
This trial is conducted in Asia. The trial is designed to compare the effect on glycaemic control of liraglutide or glimepiride added to metformin in subjects with type 2 diabetes

Detailed description:

Arms:
arm 1: Liraglutide 0.6 mg + metformin + glimepiride placebo arm 2: Liraglutide 1.2 mg + metformin + glimepiride placebo arm 3: Liraglutide + metformin + glimepiride placebo arm 4: Glimepiride 4.0 mg + metformin + liraglutide placebo

Interventions: intervention 1: liraglutide intervention 2: placebo intervention 3: liraglutide intervention 4: liraglutide intervention 5: glimepiride intervention 6: metformin intervention 7: placebo
Intervention descriptions: intervention 1: 0.6 mg/day, s.c. (under the skin) injection intervention 2: Glimepiride placebo, capsules intervention 3: 1.2 mg/day, s.c. (under the skin) injection intervention 4: 1.8 mg/day, s.c. (under the skin) injection intervention 5: Capsules, 4.0 mg/day intervention 6: Tablets, 1.5-2.0 g/day intervention 7: Liraglutide placebo, s.c. (under the skin) injection

Protocol document: